Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes
Graphical abstract
Introduction
Persistent ST-segment elevation usually correlates with acute total or nearly total occlusion of the infarct-related artery (oIRA). Therefore, primary percutaneous coronary intervention (PCI) is currently the preferred strategy in ST-elevation myocardial infarction [1]. By contrast, non-ST-segment-elevation acute coronary syndromes (NSTE-ACS) represent a wide spectrum of clinical entities usually associated with rupture of an atherosclerotic plaque, resulting in an intermittent or incomplete thrombotic occlusion of the IRA [2]. Accordingly, NSTE-ACS management is guided by risk stratification, with an early invasive approach favoured in high-risk patients [2]. However, ST-segment elevation is a relatively insensitive marker for acute occlusion of the posterior coronary circulation, particularly the left circumflex coronary artery [3]. In this context, oIRA have been previously reported in about one-third of patients with NSTE-ACS [4,5]. Notwithstanding this relatively high prevalence, it remains controversial whether oIRA itself may pose increased mortality risk compared with a patent infarct-related artery (pIRA) [4,5]. Indeed, some studies have suggested worse clinical outcomes for oIRA [[6], [7], [8], [9], [10]], while other reported otherwise [[11], [12], [13], [14], [15], [16], [17]].
Given these conflicting data and the increasing incidence of NSTE-ACS worldwide, it makes sense to provide additional data and extend the currently available evidence regarding the prognostic impact of oIRA in this clinical scenario. Thus, this study aimed to assess the prevalence, determinants, and prognostic significance of oIRA in patients with NSTE-ACS.
Section snippets
Design and study population
This is a retrospective analysis of prospectively collected data from a single-center cohort of NSTE-ACS patients included in the ARIAM-Andalusia (Analysis of Delay in Acute Myocardial Infarction in Andalusia) Registry. The study protocol has been described in detail elsewhere [18,19]. Briefly, the ARIAM-Andalusia Project is an ongoing, prospective, multicenter, observational registry involving consecutive patients with ACS admitted to cardiac care units in the Autonomous Community of Andalusia
Results
Out of 2203 ACS patients screened, 568 with NSTE-ACS who fulfilled the inclusion and exclusion criteria, constituted the study population (Fig. 1). Of these, 183 (32.5%) patients were found to have an oIRA. Baseline characteristics and clinical presentation were broadly similar between groups (Table 1). Approximately 90% of patients received aspirin and P2Y12 inhibitors prior to angiography without significant differences across groups, though patients with oIRA received more frequently potent
Discussion
Main findings in the present study can be summarized as follow: (1) in current practice, almost one third of patients with NSTE-ACS had oIRA; (2) readily available markers proved helpful for predicting oIRA in a contemporary NSTE-ACS population; (3) the presence of an oIRA did not appear to portend poorer clinical outcomes as compared with pIRA; (4) however, exposure effects of oIRA on outcomes varied according to the degree of completeness of revascularization. Thereby, the extent of coronary
Study limitations
As with all retrospective studies, potential selection bias and residual confounding cannot be excluded. Therefore, the current analysis cannot address causality, and findings should still be considered hypothesis generating, rather than hypothesis testing. Likewise, information on the decision-making process for coronary revascularization was not adequately captured. Despite the monocentric nature and extrict exclusion criteria in this study may pose constraints on generalizability of results,
Conclusions
In this contemporary real-world study, the presence of oIRA in approximately one third of patients with NSTE-ACS did not seem to confer a significant increase in the 30-day risk of MACE compared with a pIRA. This neutral exposure effects of oIRA appeared to be largely driven by the joint effects of completeness of revascularization and the IRA patency on mortality risk, such that the negative impact of IR was much greater in patients with pIRA than in those with oIRA.
The current study
Authorship
All the authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Funding
None.
Author statement
All authors contributed and participated in the preparation of the manuscript and research steps in the present study as follows:
- Conception and design: MAD.
- Data collection: JCGR, MAD, PVC, MGR, TSG, NGG, MPRG, FJCC, BLL.
- Data Curation: MDA, JCGR.
- Endpoint/IRA validation: pair#1 (JCGR, TSG); pair#2 (RJHU, MAD).
- Statistical analysis and writing of original draft: MAD.
- Reading, critical review and final approval for submission: All.
Declaration of Competing Interest
None.
References (29)
- et al.
National Cardiovascular Data Registry. Anatomic distribution of the culprit lesion in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: findings from the National Cardiovascular Data Registry
J Am Coll Cardiol.
(2008) - et al.
Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-thrombolysis in myocardial infarction 38) substudy
J. Am. Coll. Cardiol. Intv.
(2010) - et al.
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non ST elevation acute coronary syndromes undergoing diagnostic angiography
Am. Heart J.
(2009) - et al.
Non ST elevation myocardial infarction with occluded artery and its clinical implications
Heart Lung Circ.
(2014) - et al.
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction
Am. J. Cardiol.
(2015) - et al.
Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: results from the FAST-MI 2010 registry
Arch Cardiovasc Dis.
(2018) - et al.
Safety and efficacy of prasugrel and ticagrelor in acute coronary syndrome. Results of a "Real World" Multicenter Registry
Rev Esp Cardiol (Engl Ed).
(2017) - et al.
Angiographic evolution of coronary artery morphology in unstable angina
J. Am. Coll. Cardiol.
(1986) - et al.
Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention
Am. J. Cardiol.
(2015) - et al.
Complete versus culprit-only lesion intervention in patients with acute coronary syndromes
J. Am. Coll. Cardiol.
(2018)
Impact of chronic total occlusion artery on 12-month mortality in patients with non-ST-segment elevation myocardial infarction treated by percutaneous coronary intervention (from the PL-ACS registry)
Int. J. Cardiol.
Area at risk and collateral circulation in a first acute myocardial infarction with occluded culprit artery. STEMI vs non-STEMI patients
Int. J. Cardiol.
2018 ESC/EACTS Guidelines on myocardial revascularization
Eur. Heart J.
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Eur. Heart J.
Cited by (4)
Acute coronary occlusion in non-STEMI: If you change the way you look at things, the things you look at change
2021, International Journal of CardiologyComparing Door-To-Balloon Time between ST-Elevation Myocardial Infarction Electrocardiogram and Its Equivalents
2022, Journal of Clinical Medicine